184 related articles for article (PubMed ID: 27555667)
1. Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
Trentini A; Castellazzi M; Cervellati C; Manfrinato MC; Tamborino C; Hanau S; Volta CA; Baldi E; Kostic V; Drulovic J; Granieri E; Dallocchio F; Bellini T; Dujmovic I; Fainardi E
Dis Markers; 2016; 2016():3672353. PubMed ID: 27555667
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.
Liuzzi GM; Trojano M; Fanelli M; Avolio C; Fasano A; Livrea P; Riccio P
Mult Scler; 2002 May; 8(3):222-8. PubMed ID: 12120694
[TBL] [Abstract][Full Text] [Related]
5. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes.
Avolio C; Ruggieri M; Giuliani F; Liuzzi GM; Leante R; Riccio P; Livrea P; Trojano M
J Neuroimmunol; 2003 Mar; 136(1-2):46-53. PubMed ID: 12620642
[TBL] [Abstract][Full Text] [Related]
6. Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.
Castellazzi M; Bellini T; Trentini A; Delbue S; Elia F; Gastaldi M; Franciotta D; Bergamaschi R; Manfrinato MC; Volta CA; Granieri E; Fainardi E
Dis Markers; 2016; 2016():8434209. PubMed ID: 27340316
[TBL] [Abstract][Full Text] [Related]
7. Serum and CSF cytokines and matrix metalloproteinases in spinal tuberculosis.
Patil T; Garg RK; Jain A; Goel MM; Malhotra HS; Verma R; Singh GP; Sharma PK
Inflamm Res; 2015 Feb; 64(2):97-106. PubMed ID: 25503789
[TBL] [Abstract][Full Text] [Related]
8. Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis.
Sanchooli J; Ramroodi N; Sanadgol N; Sarabandi V; Ravan H; Rad RS
Kaohsiung J Med Sci; 2014 May; 30(5):235-42. PubMed ID: 24751386
[TBL] [Abstract][Full Text] [Related]
9. Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
Alexander JS; Harris MK; Wells SR; Mills G; Chalamidas K; Ganta VC; McGee J; Jennings MH; Gonzalez-Toledo E; Minagar A
Mult Scler; 2010 Jul; 16(7):801-9. PubMed ID: 20621951
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease.
Hamzaoui K; Maître B; Hamzaoui A
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S52-7. PubMed ID: 19796534
[TBL] [Abstract][Full Text] [Related]
11. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
Fainardi E; Castellazzi M; Tamborino C; Trentini A; Manfrinato MC; Baldi E; Tola MR; Dallocchio F; Granieri E; Bellini T
Mult Scler; 2009 May; 15(5):547-54. PubMed ID: 19318509
[TBL] [Abstract][Full Text] [Related]
12. Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Dixit P; Garg RK; Malhotra HS; Jain A; Verma R; Sharma PK; Kumar N
Inflamm Res; 2016 Feb; 65(2):125-32. PubMed ID: 26608499
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of matrix metalloproteinase-2, -9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity.
Amini R; Karampoor S; Zahednasab H; Keyvani H; Gheiasian M; Jalilian FA
Braz J Infect Dis; 2020; 24(2):144-149. PubMed ID: 32243867
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis.
Beuche W; Yushchenko M; Mäder M; Maliszewska M; Felgenhauer K; Weber F
Neuroreport; 2000 Nov; 11(16):3419-22. PubMed ID: 11095490
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
[TBL] [Abstract][Full Text] [Related]
18. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
Hopps E; Lo Presti R; Montana M; Noto D; Averna MR; Caimi G
J Investig Med; 2013 Aug; 61(6):978-83. PubMed ID: 23661104
[TBL] [Abstract][Full Text] [Related]
19. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment.
Avolio C; Filippi M; Tortorella C; Rocca MA; Ruggieri M; Agosta F; Tomassini V; Pozzilli C; Stecchi S; Giaquinto P; Livrea P; Trojano M
Mult Scler; 2005 Aug; 11(4):441-6. PubMed ID: 16042227
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.
Li S; Wu Y; Keating SM; Du H; Sammet CL; Zadikoff C; Mahadevia R; Epstein LG; Ragin AB
J Neurovirol; 2013 Oct; 19(5):452-60. PubMed ID: 23979706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
